These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls. Sterling TR Int J Tuberc Lung Dis; 2004 Dec; 8(12):1396-400. PubMed ID: 15636484 [TBL] [Abstract][Full Text] [Related]
6. Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? Abiad H Clin Infect Dis; 2002 Dec; 35(12):1572; author reply 1572-3. PubMed ID: 12471582 [No Abstract] [Full Text] [Related]
7. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy]. Garin N; Nendaz M Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity. Singh A Clin Infect Dis; 2007 Jul; 45(1):133; author reply 134-5. PubMed ID: 17554716 [No Abstract] [Full Text] [Related]
9. Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis. Golub JE; Bur S; Cronin WA; Gange S; Sterling TR; Oden B; Baruch N; Comstock GW; Chaisson RE Int J Tuberc Lung Dis; 2005 Apr; 9(4):392-7. PubMed ID: 15832463 [TBL] [Abstract][Full Text] [Related]
10. [Use of trovafloxacin therapy in community-acquired pneumonia]. Luna CM; Gené RJ Medicina (B Aires); 1999; 59 Suppl 1():31-8. PubMed ID: 10436552 [TBL] [Abstract][Full Text] [Related]
11. [The role of quinolones in the treatment of community acquired pneumonia]. Garau J Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158 [No Abstract] [Full Text] [Related]
12. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones. Carrie AG; Kozyrskyj AL Can J Clin Pharmacol; 2006; 13(1):e102-11. PubMed ID: 16585811 [TBL] [Abstract][Full Text] [Related]
13. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866 [TBL] [Abstract][Full Text] [Related]
14. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA; Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410 [TBL] [Abstract][Full Text] [Related]
15. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
17. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Bratzler DW; Ma A; Nsa W Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289 [TBL] [Abstract][Full Text] [Related]
18. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P; Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390 [TBL] [Abstract][Full Text] [Related]
19. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones may delay the diagnosis of tuberculosis. Ang D; Hsu AA; Tan BH Singapore Med J; 2006 Sep; 47(9):747-51. PubMed ID: 16924354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]